Eudaimonia Partners’s Baxter International BAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,304
Closed -$276K 346
2022
Q2
$276K Sell
4,304
-75
-2% -$5.44K 0.05% 308
2022
Q1
$340K Buy
+4,379
New +$367K 0.06% 298
2021
Q3
$443K Buy
5,514
+1,270
+30% +$100K 0.08% 247
2021
Q2
$342K Buy
4,244
+267
+7% +$22.4K 0.06% 287
2021
Q1
$335K Sell
3,977
-10,928
-73% -$868K 0.07% 260
2020
Q4
$1.2M Buy
14,905
+484
+3% +$38.3K 0.27% 92
2020
Q3
$1.16M Buy
14,421
+10,514
+269% +$884K 0.3% 84
2020
Q2
$336K Hold
3,907
0.13% 175
2020
Q1
$317K Buy
3,907
+289
+8% +$24.9K 0.14% 165
2019
Q4
$303K Buy
+3,618
New +$299K 0.12% 191

Other funds holding BAX

Eudaimonia Partners's BAX Position: Q3 2022 in Review

Eudaimonia Partners sold out of Baxter International (BAX) in Q3 2022, closing a stake of 4,304 shares — an estimated $276K sold.

Eudaimonia Partners first reported a position in BAX in Q4 2019 and held it in 10 quarters. The position peaked at $1.2M in Q4 2020. 1,011 funds tracked by Wall St. Rank hold BAX as of Q3 2022.

  • Eudaimonia Partners reported no remaining Baxter International position as of Q3 2022 after selling out during the quarter.
  • Eudaimonia Partners sold 4,304 Baxter International shares in Q3 2022, an estimated $276K.
  • Eudaimonia Partners first reported a position in Baxter International in Q4 2019 and held it in 10 quarters.
  • Eudaimonia Partners's Baxter International position peaked at $1.2M in Q4 2020.
  • 1,011 funds tracked by Wall St. Rank held Baxter International as of Q3 2022.

Based on Eudaimonia Partners's 13F filing for Q3 2022, filed 4 Nov 2022.